CLX vs. KMB, CHD, WDFC, SPB, CENTA, ODC, PG, CL, MNST, and KDP
Should you be buying Clorox stock or one of its competitors? The main competitors of Clorox include Kimberly-Clark (KMB), Church & Dwight (CHD), WD-40 (WDFC), Spectrum Brands (SPB), Central Garden & Pet (CENTA), Oil-Dri Co. of America (ODC), Procter & Gamble (PG), Colgate-Palmolive (CL), Monster Beverage (MNST), and Keurig Dr Pepper (KDP).
Kimberly-Clark (NYSE:KMB) and Clorox (NYSE:CLX) are both large-cap consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, community ranking, institutional ownership, earnings, media sentiment and analyst recommendations.
Kimberly-Clark has higher revenue and earnings than Clorox. Kimberly-Clark is trading at a lower price-to-earnings ratio than Clorox, indicating that it is currently the more affordable of the two stocks.
In the previous week, Kimberly-Clark had 6 more articles in the media than Clorox. MarketBeat recorded 14 mentions for Kimberly-Clark and 8 mentions for Clorox. Kimberly-Clark's average media sentiment score of 0.94 beat Clorox's score of 0.87 indicating that Clorox is being referred to more favorably in the news media.
76.3% of Kimberly-Clark shares are owned by institutional investors. Comparatively, 78.5% of Clorox shares are owned by institutional investors. 0.6% of Kimberly-Clark shares are owned by company insiders. Comparatively, 0.5% of Clorox shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Kimberly-Clark received 179 more outperform votes than Clorox when rated by MarketBeat users. Likewise, 49.91% of users gave Kimberly-Clark an outperform vote while only 39.98% of users gave Clorox an outperform vote.
Kimberly-Clark has a net margin of 9.05% compared to Kimberly-Clark's net margin of 3.33%. Kimberly-Clark's return on equity of 302.49% beat Clorox's return on equity.
Kimberly-Clark currently has a consensus target price of $137.85, suggesting a potential upside of 1.31%. Clorox has a consensus target price of $146.43, suggesting a potential upside of 9.30%. Given Kimberly-Clark's higher possible upside, analysts plainly believe Clorox is more favorable than Kimberly-Clark.
Kimberly-Clark pays an annual dividend of $4.88 per share and has a dividend yield of 3.6%. Clorox pays an annual dividend of $4.80 per share and has a dividend yield of 3.6%. Kimberly-Clark pays out 89.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Clorox pays out 248.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Kimberly-Clark has raised its dividend for 53 consecutive years and Clorox has raised its dividend for 46 consecutive years.
Kimberly-Clark has a beta of 0.38, meaning that its stock price is 62% less volatile than the S&P 500. Comparatively, Clorox has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500.
Summary
Kimberly-Clark beats Clorox on 13 of the 21 factors compared between the two stocks.
Get Clorox News Delivered to You Automatically
Sign up to receive the latest news and ratings for CLX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
